Showing 581 - 600 results of 101,410 for search '(( end point decrease ) OR ( 5 ((ng decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.35s Refine Results
  1. 581

    Image1_Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models.jpg by Karthikeyan Selvarasu (14004867)

    Published 2022
    “…We also found that the knockdown and knockout (KO) of KIFf5B significantly decreased the tau stability, and overexpression of KIF5B in KIF5B-KO cells significantly increased the expression of phosphorylated and total tau levels. …”
  2. 582
  3. 583
  4. 584

    Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs by Olivier Reynard (354756)

    Published 2016
    “…In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. …”
  5. 585
  6. 586
  7. 587
  8. 588

    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

    Published 2019
    “…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
  9. 589
  10. 590

    Inhibition of the <i>Hedgehog</i> pathway leads to decreased ostegenesis <i>in vitro</i>. by Emily R. Nelson (247130)

    Published 2013
    “…<p>(A–B) qRT-PCR of e13.5 wild-type, CD-1 palate cultures treated with DMEM F12 +/− supplementation with cyclopamine (20 mM) or Shh-N (250 ng/mL) for 2 days. …”
  11. 591
  12. 592

    Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera by Angela Bozza (8908091)

    Published 2023
    “…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2<sup>V617F</sup>), JAK2 inhibitors have been tested as second-line therapies. …”
  13. 593
  14. 594
  15. 595
  16. 596
  17. 597
  18. 598
  19. 599
  20. 600